186 related articles for article (PubMed ID: 25153773)
1. Mental health outcomes in elderly men with prostate cancer.
Ravi P; Karakiewicz PI; Roghmann F; Gandaglia G; Choueiri TK; Menon M; McKay RR; Nguyen PL; Sammon JD; Sukumar S; Varda B; Chang SL; Kibel AS; Sun M; Trinh QD
Urol Oncol; 2014 Nov; 32(8):1333-40. PubMed ID: 25153773
[TBL] [Abstract][Full Text] [Related]
2. Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting.
Berge V; Thompson T; Blackman D
Scand J Urol Nephrol; 2007; 41(3):198-203. PubMed ID: 17469027
[TBL] [Abstract][Full Text] [Related]
3. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
[TBL] [Abstract][Full Text] [Related]
4. Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study.
Crump C; Stattin P; Brooks JD; Sundquist J; Edwards AC; Sundquist K; Sieh W
J Natl Cancer Inst; 2024 May; 116(5):745-752. PubMed ID: 38060258
[TBL] [Abstract][Full Text] [Related]
5. Impact of initial local therapy on survival in men later receiving chemotherapy for prostate cancer: a population-based, propensity-weighted multivariable analysis.
Zabell JR; Adejoro O; Jarosek SL; Elliott SP; Konety BR
World J Urol; 2016 Oct; 34(10):1397-403. PubMed ID: 26914817
[TBL] [Abstract][Full Text] [Related]
6. Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation.
Sun M; Sammon JD; Becker A; Roghmann F; Tian Z; Kim SP; Larouche A; Abdollah F; Hu JC; Karakiewicz PI; Trinh QD
BJU Int; 2014 Feb; 113(2):200-8. PubMed ID: 23937636
[TBL] [Abstract][Full Text] [Related]
7. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.
Fang F; Keating NL; Mucci LA; Adami HO; Stampfer MJ; Valdimarsdóttir U; Fall K
J Natl Cancer Inst; 2010 Mar; 102(5):307-14. PubMed ID: 20124521
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer.
Punnen S; Cowan JE; Dunn LB; Shumay DM; Carroll PR; Cooperberg MR
BJU Int; 2013 Jul; 112(2):E67-75. PubMed ID: 23795800
[TBL] [Abstract][Full Text] [Related]
9. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
Culp SH; Schellhammer PF; Williams MB
Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
[TBL] [Abstract][Full Text] [Related]
10. Marital status and prostate cancer outcomes.
Tyson MD; Andrews PE; Etzioni DA; Ferrigni RG; Humphreys MR; Swanson SK; Castle EK
Can J Urol; 2013 Apr; 20(2):6702-6. PubMed ID: 23587510
[TBL] [Abstract][Full Text] [Related]
11. Effect of depression on diagnosis, treatment, and mortality of men with clinically localized prostate cancer.
Prasad SM; Eggener SE; Lipsitz SR; Irwin MR; Ganz PA; Hu JC
J Clin Oncol; 2014 Aug; 32(23):2471-8. PubMed ID: 25002728
[TBL] [Abstract][Full Text] [Related]
12. Risk of hospitalisation after primary treatment for prostate cancer.
Williams SB; Duan Z; Chamie K; Hoffman KE; Smith BD; Hu JC; Shah JB; Davis JW; Giordano SH
BJU Int; 2017 Jul; 120(1):48-55. PubMed ID: 27561186
[TBL] [Abstract][Full Text] [Related]
13. Morbidity and costs of salvage vs. primary radical prostatectomy in older men.
Prasad SM; Gu X; Kowalczyk KJ; Lipsitz SR; Nguyen PL; Hu JC
Urol Oncol; 2013 Nov; 31(8):1477-82. PubMed ID: 22575240
[TBL] [Abstract][Full Text] [Related]
14. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
[TBL] [Abstract][Full Text] [Related]
15. Effect of Socioeconomic Disparities on Suicide Risk in Patients With Prostate Cancer During 2005 to 2020: A Population Study.
Jia YJ; Hu FH; Tang W; Zhang WQ; Ge MW; Shen LT; Hu SQ; Shen WQ; Chen HL
Clin Genitourin Cancer; 2024 Apr; 22(2):84-91.e7. PubMed ID: 37758561
[TBL] [Abstract][Full Text] [Related]
16. The characteristics of bladder cancer after radiotherapy for prostate cancer.
Abern MR; Dude AM; Tsivian M; Coogan CL
Urol Oncol; 2013 Nov; 31(8):1628-34. PubMed ID: 22575239
[TBL] [Abstract][Full Text] [Related]
17. Survival associated with treatment vs observation of localized prostate cancer in elderly men.
Wong YN; Mitra N; Hudes G; Localio R; Schwartz JS; Wan F; Montagnet C; Armstrong K
JAMA; 2006 Dec; 296(22):2683-93. PubMed ID: 17164454
[TBL] [Abstract][Full Text] [Related]
18. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
[TBL] [Abstract][Full Text] [Related]
19. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
[TBL] [Abstract][Full Text] [Related]
20. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
